Cargando…

Inflammasome in ALS Skeletal Muscle: NLRP3 as a Potential Biomarker

Since NLRP3 inflammasome plays a pivotal role in several neurodegenerative disorders, we hypothesized that levels of inflammasome components could help in diagnosis or prognosis of amyotrophic lateral sclerosis (ALS). Gene and protein expression was assayed by RT-PCR and Western blot. Spearman’s cor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moreno-García, Leticia, Miana-Mena, Francisco J., Moreno-Martínez, Laura, de la Torre, Miriam, Lunetta, Christian, Tarlarini, Claudia, Zaragoza, Pilar, Calvo, Ana Cristina, Osta, Rosario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959138/ https://www.ncbi.nlm.nih.gov/pubmed/33802349 http://dx.doi.org/10.3390/ijms22052523

Ejemplares similares

Type XIX collagen: a promising biomarker from the basement membranes
por: Calvo, Ana C., et al.
Publicado: (2019)

Neuroprotective Fragment C of Tetanus Toxin Modulates IL-6 in an ALS Mouse Model
por: Moreno-Martinez, Laura, et al.
Publicado: (2020)

Time-Point Dependent Activation of Autophagy and the UPS in SOD1G93A Mice Skeletal Muscle
por: Oliván, Sara, et al.
Publicado: (2015)

Circulating Cytokines Could Not Be Good Prognostic Biomarkers in a Mouse Model of Amyotrophic Lateral Sclerosis
por: Moreno-Martínez, Laura, et al.
Publicado: (2019)

The role of NLRP3 inflammasome in inflammation-related skeletal muscle atrophy
por: Liu, Yukun, et al.
Publicado: (2022)

Competing Endogenous RNA Networks as Biomarkers in Neurodegenerative Diseases
por: Moreno-García, Leticia, et al.
Publicado: (2020)

The NLRP3 inflammasome contributes to inflammation‐induced morphological and metabolic alterations in skeletal muscle
por: Eggelbusch, Moritz, et al.
Publicado: (2022)

Mitochondrial Aconitase Enzymatic Activity: A Potential Long-Term Survival Biomarker in the Blood of ALS Patients
por: González-Mingot, Cristina, et al.
Publicado: (2023)

Chemotherapeutic agent 5-fluorouracil increases survival of SOD1 mouse model of ALS
por: Rando, Amaya, et al.
Publicado: (2019)

Effects of gene therapy on muscle 18S rRNA expression in mouse model of ALS
por: Moreno-Igoa, María, et al.
Publicado: (2010)

Inflammasome in Skeletal Muscle: NLRP3 Is an Inflammatory Cell Stress Component in Inclusion Body Myositis
por: Kummer, Karsten, et al.
Publicado: (2023)

Lack of a synergistic effect of a non-viral ALS gene therapy based on BDNF and a TTC fusion molecule
por: Calvo, Ana C, et al.
Publicado: (2011)

Hemizygous Granzyme A Mice Expressing the hSOD1G93A Transgene Show Slightly Extended Lifespan
por: Moreno-Martinez, Laura, et al.
Publicado: (2022)

NLRP3 Inflammasome: Potential Role in Obesity Related Low-Grade Inflammation and Insulin Resistance in Skeletal Muscle
por: Jorquera, Gonzalo, et al.
Publicado: (2021)

Collagen XIX Alpha 1 Improves Prognosis in Amyotrophic Lateral Sclerosis
por: Calvo, Ana C., et al.
Publicado: (2019)

Sex Differences in Constitutive Autophagy
por: Oliván, Sara, et al.
Publicado: (2014)

The NLRP6 inflammasome
por: Zheng, Danping, et al.
Publicado: (2020)

The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease
por: Saresella, Marina, et al.
Publicado: (2016)

Inflammatory and non-inflammatory monocytes as novel prognostic biomarkers of survival in SOD1G93A mouse model of Amyotrophic Lateral Sclerosis
por: Gasco, Samanta, et al.
Publicado: (2017)

Constitutively Activated NLRP3 Inflammasome Causes Inflammation and Abnormal Skeletal Development in Mice
por: Bonar, Sheri L., et al.
Publicado: (2012)

Genetic Biomarkers for ALS Disease in Transgenic SOD1(G93A) Mice
por: Calvo, Ana C., et al.
Publicado: (2012)

The NLRP3 and Pyrin Inflammasomes: Implications in the Pathophysiology of Autoinflammatory Diseases
por: de Torre-Minguela, Carlos, et al.
Publicado: (2017)

Commentary on Camell et al., Aging Induces Nlrp3 Inflammasome Dependent Adipose B Cell Expansion to Impair Metabolic Homeostasis
por: SantaCruz-Calvo, Sara, et al.
Publicado: (2020)

Fragment C of Tetanus Toxin: New Insights into Its Neuronal Signaling Pathway
por: Calvo, Ana C., et al.
Publicado: (2012)

Inhibiting the NLRP3 Inflammasome
por: El-Sharkawy, Lina Y., et al.
Publicado: (2020)

Comparative study of behavioural tests in the SOD1G93A mouse model of amyotrophic lateral sclerosis
por: OLIVÁN, Sara, et al.
Publicado: (2014)

Research Progress of Mitochondrial Mechanism in NLRP3 Inflammasome Activation and Exercise Regulation of NLRP3 Inflammasome
por: Zhang, Tan, et al.
Publicado: (2021)

The Role of Inflammasome-Dependent and Inflammasome-Independent NLRP3 in the Kidney
por: Kim, Yang Gyun, et al.
Publicado: (2019)

The Impact of Melatonin and NLRP3 Inflammasome on the Expression of microRNAs in Aged Muscle
por: Sayed, Ramy KA, et al.
Publicado: (2021)

Activation of the NLRP3 Inflammasome Increases the IL-1β Level and Decreases GLUT4 Translocation in Skeletal Muscle during Insulin Resistance
por: Américo-Da-Silva, Luan, et al.
Publicado: (2021)

The role of the NLRP3 inflammasome in gout
por: Kingsbury, Sarah R, et al.
Publicado: (2011)

The Role of the NLRP3 Inflammasome in Fibrosis
por: Artlett, Carol M
Publicado: (2012)

NLRP3 Inflammasome and MS/EAE
por: Inoue, Makoto, et al.
Publicado: (2013)

NLRP3 Inflammasome and Pathobiology in AMD
por: Celkova, Lucia, et al.
Publicado: (2015)

Role of the NLRP3 inflammasome in cancer
por: Moossavi, Maryam, et al.
Publicado: (2018)

Spotlight on the NLRP3 inflammasome pathway
por: Groslambert, Marine, et al.
Publicado: (2018)

Regulation of NLRP3 Inflammasome by Phosphorylation
por: Song, Nan, et al.
Publicado: (2018)

Role of NLRP3 Inflammasomes in Atherosclerosis
por: Karasawa, Tadayoshi, et al.
Publicado: (2017)

NLRP3 inflammasome in endothelial dysfunction
por: Bai, Baochen, et al.
Publicado: (2020)

The NLRP1 and CARD8 inflammasomes
por: Taabazuing, Cornelius Y., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fmq7fs4jig75v0kk6c67usjql5